Christopher Flint OBrien, Chief Medical Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 2,412 shares at $43.17 ($104K) on 2017-02-06, disclosed to the SEC on 2017-02-08.
Open-market sale of $104k NBIX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.17 | 1,206 | $52K | 50.0% |
| 2 | $43.17 | 1,206 | $52K | 50.0% |
| Total | $43.17 avg | 2,412 | $104K | 100% |
| Filing → |
| NBIX | SELL | 2017-11-06 | $7.4M | — | Filing → |
| NBIX | SELL | 2017-10-03 | $423K | — | Filing → |
| NBIX | SELL | 2017-09-07 | $6.1M | — | Filing → |